Hema Now
Sagar Lonial discusses advances in multiple myeloma treatment, the evolving role of immunotherapy and minimal residual disease, unmet needs in relapsed disease, lessons from research, and emerging technologies shaping future care.
Spotify | Apple | Amazon Music | YouTube | Download MP3
Sagar Lonial is Professor and Chair of Hematology and Medical Oncology at Emory University School of Medicine, and Chief Medical Officer of Winship Cancer Institute, Atlanta, Georgia, USA. He specialises in multiple myeloma and plasma cell disorders.
Timestamps:
00:00 – Introduction
01:24 – Inspiration for Myeloma Research
03:20 – Transformative Myeloma Treatment Developments
05:03 – Translating Science into Treatment
07:41 – Future of Immunotherapy in Myeloma
09:45 – Unmet Needs After Relapse
10:53 – Lessons from Research Setbacks
13:05 – Future Role of MRD Assessment
15:50 – Fostering Research Innovation
17:50 – Emerging Advances in Myeloma
19:45 – Three Wishes for Myeloma
Keywords:
Cellular therapy, immunotherapy, minimal residual disease (MRD), multiple myeloma.
